n n n n n
PULMONARY FUNCTION TESTING 12TH EDITION,
n n n n n
BY MOTTRAM
n n
CHAPTER 1 - 13 UPDATED
n n n n n
,Chapter 1: Indications for Pulmonary Function Testing Test
n n n n n n n
Bank
n
MULTIPLE nCHOICE
1. Who nfirst npopularized nspirometry nfor nthe nevaluation nof npulmonary nfunction?
a. August nand nMarie nKrogh
b. Alvan nBarach
c. John nSeveringhaus
d. John nHutchinson
ANS: nD
Hutchinson npopularized nthe nconcept nof nusing nVC nto nassess nlung nfunction, nand nthe
nnames nhe ngave nto nseveral nother nlung n compartments nare n still nused ntoday.
DIF: 1 REF: p. n2 OBJ: None n MSC: nNBRC: nNone
2. Which nof nthe nfollowing nare nindications nfor nperforming nspirometry?
1. Assess nthe nrisk nof nlung nresection.
2. Determine nthe nresponse nto nbronchodilator ntherapy.
3. Assess nthe nseverity nof nrestrictive nlung ndisease.
4. Quantify nthe nextent nof nCOPD.
a. 1 n and n 4
b. 2 n and n 3
c. 1 n, n2, nand n 4
d. 2 n, n3, nand n 4
ANS: nC
Spirometry ncannot nassess nseverity nof nrestriction; nfor nthat nyou nneed nto nmeasure
nlung nvolumes n( nsee nBox n1-2, nChapter n 1).
DIF: 1 REF: p. n7 OBJ: EL-2 MSC: nNBRC: nNone
,3. The nmain nindication nfor nthe nmeasurement nof nlung nvolumes nis nto ndo nwhich nof nthe
nfollowing?
a. Diagnose nor nassess nthe nseverity nof nrestriction.
b. Evaluate nthe nseverity nof npulmonary nhypertension.
c. Determine nthe nlevel nof ncardiopulmonary nfitness.
d. Assess nthe nrisk nof nabdominal nsurgical nprocedures.
ANS: nA
The nmost ncommon nreason nfor nmeasuring nlung nvolumes nis nto nidentify nrestrictive
nlung ndisease. nDIF: 1 REF: p. n35 OBJ: EL-2 MSC: nNBRC: nNone
4. DLCO nmeasurements nmay nbe nindicated nto nevaluate npulmonary ninvolvement nin
nwhich nof nthe nfollowing nsystemic ndiseases?
a. Asthma
b. Sarcoidosis
c. Exertional nhypoxemia
, Stuvia.com n- nThe nMarketplace nto nBuy nand nSell nyour nStudy
nMaterial
d. Guillain-Barré nsyndrome
ANS: nB
Sarcoidosis nis nthe nonly nsystemic ndisease nlisted nthat naffects ngas
nexchange. nDIF: n1 nREF: np. n9 n| np. n19 n| np. n21 n| np. n35 nOBJ: nEL-2
nMSC: nNBRC: nNone
5. Blood ngas nanalysis nis nused nwith npatients nwith nCOPD nto ndo
nwhich nof nthe nfollowing?
a. Monitor nairway nresponsiveness.
b. Determine nlevel nof ncardiopulmonary nfitness.
c. Detect npulmonary nhypertension.
d. Assess nneed nfor nsupplementary nO2.
ANS: nD
Blood ngas nanalysis nis nmost ncommonly nused nto ndetermine nthe nneed nfor
nsupplemental noxygen nand nto nmanage npatients nwho nrequire nventilatory
nsupport.
DIF: 2 REF: p. n15 OBJ: EL-1
nMSC: nNBRC: n CPFT n2A-2
6. Which nof nthe nfollowing ncause nemphysema?
1. 1- nAntitrypsin ndeficiency
2. Exposure nto nenvironmental npollutants
3. Radiation ntherapy
4. Cigarette nsmoking
a. 1 n and n 2
b. 3 n and n 4
c. 1 n, n2, nand n 4
d. 2 n, n3, nand n 4
ANS: nC
Emphysema nis ncaused nprimarily nby ncigarette nsmoking. nSome nemphysema nis
ncaused nby nthe nabsence n of na n protective nenzyme. nChronic nexposure nto
nenvironmental npollutants ncan nalso ncontribute nto nthe ndevelopment nof
nemphysema.
DIF: 1 REF: p. n11 OBJ: EL-3 n| nAL-2 MSC: nNBRC: nNone
7. An nadult npatient ncomplains nof nchest ntightness nand ncough nwhenever nhe njogs nin
ncold nweather. nThese nsymptoms nare nconsistent nwith nwhich n of nthe nfollowing?
a. Cystic nfibrosis
b. Asthma
c. Pulmonary nhypertension
|